Pharma

Your Article Summary

See Latest Articles

Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease
Novartis, 09/28/09

Novartis has received a positive opinion recommending European Union approval of QAB149 for maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease . When approved, QAB149 and its device, Concept–1, will be known as Onbrez Breezhaler.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals